Latest in Biotech
Sort by
2 items
-
Corvex’s Meister joins the board at Illumina. Here’s how he can create value for shareholders
Keith Meister, Corvex Management's chief investment officer, will join Illumina's board starting March 28. He's no stranger to the world of biotech.CNBC - 3d -
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
Shares of Moderna, Novavax and other biotech companies fell after FDA official Peter Marks's resignation in protest of Robert F. Kennedy Jr.CNBC - 1d